Compliance statement
This study was a systematic review and meta-analysis of previously published studies. No new human participants were recruited, no individual patient data were collected, and institutional ethics approval and informed consent were not required. The protocol was not prospectively registered; this limitation is acknowledged in the interpretation of the findings. All the materials and tools used in this study are listed in the Table of Materials.
Study design and literature search
A systematic review and meta-analysis were conducted in accordance with PRISMA 2020 guidance1. Before screening, eligibility criteria were defined using the PICOS framework. The population consisted of adults undergoing abdominal surgery. Eligible interventions were perioperative incisional wound management or SSI prevention strategies, including antiseptic skin preparation, intraoperative wound irrigation, closed incision negative pressure wound therapy, wound protectors, antimicrobial or antiseptic wound-related measures, and multimodal prevention bundles. Comparators included routine care, placebo, saline, standard dressing, non-antimicrobial materials, preimplementation usual care, or another active comparator. Outcomes included SSI, superficial or deep incisional SSI, wound dehiscence, delayed healing, seroma, wound-related readmission, reoperation, length of hospital stay, pain, scar quality, and quality of life.
PubMed, Embase, Web of Science, and Cochrane CENTRAL were searched from January 1, 2023, to March 14, 2026. For each database, the platform, exact search date, complete search string, and number of records retrieved were recorded. The search combined abdominal surgery terms, wound-healing or SSI terms, and intervention terms such as chlorhexidine, povidone-iodine, wound irrigation, negative-pressure wound therapy, wound protector, and prevention bundle. The full reproducible search strategy is provided in Table 1. All retrieved records were imported into a reference manager or systematic review screening tool. Automatic duplicate removal was followed by manual comparison of author names, titles, years, trial acronyms, registry numbers, and sample sizes. Two reviewers independently screened titles and abstracts, retrieved the full texts of potentially eligible studies, and assessed them independently. Disagreements were resolved through discussion or consultation with a third reviewer. One primary exclusion reason was recorded for each excluded full-text article.
Eligibility criteria and data extraction
Eligible studies were required to include adult patients undergoing abdominal surgery, evaluate at least one perioperative incisional wound management or SSI prevention intervention, include a comparator group, and report at least one wound-related clinical outcome. Randomized controlled trials, cluster-randomized trials, pragmatic trials, prospective comparative studies, retrospective comparative studies, and before-and-after implementation studies were eligible. Animal experiments, in vitro studies, reviews, meta-analyses, editorials, letters, case reports, conference abstracts without extractable data, studies without a comparator, non-abdominal surgery studies, and duplicate or overlapping reports were excluded.
Two reviewers independently extracted data using a predefined extraction form. Extracted items included author, year, country, study design, setting, sample size, surgical population, intervention category, intervention details, comparator details, follow-up duration, outcome definition, number of events, and total participants for dichotomous outcomes, mean, standard deviation, and sample size for continuous outcomes, adjusted effect estimates when reported, funding, conflicts of interest, and risk of bias notes.
For missing or unclear data, supplementary materials, appendices, trial registries, and published protocols were checked first. If data remained unavailable, the corresponding author was contacted. If no response was obtained, the outcome was marked as not extractable and was not imputed unless a prespecified imputation rule was applicable. Duplicate reports from the same cohort were handled by retaining the report with the largest sample size, most complete wound outcome reporting, or most relevant follow-up.
Quality assessment and statistical analysis
Risk of bias was assessed independently by two reviewers. Randomized trials were assessed using the Cochrane Risk of Bias 2 tool, including randomization process, deviations from intended interventions, missing outcome data, outcome measurement, and selection of reported results. Cluster randomized and crossover trials were assessed using the corresponding RoB 2 extensions. Non-randomized comparative studies were assessed using ROBINS I or the Newcastle Ottawa Scale, with attention to confounding, participant selection, intervention classification, deviations from intended interventions, missing data, outcome measurement, and selective reporting. Domain-level judgments were recorded for each study.
For short-term dichotomous wound outcomes, risk ratios (RRs) with 95% confidence intervals (CIs) were used as the primary effect measure. Hazard ratios were not used for binary SSI or wound-complication outcomes unless the original study reported time-to-event data and the outcome was analyzed as time to event. For continuous outcomes, mean differences (MDs) were used when measurement scales were identical, and standardized mean differences (SMDs) were used when scales differed. Random-effects models were used as the primary approach because the included interventions, surgical populations, comparators, and outcome definitions were clinically heterogeneous.
Heterogeneity was assessed using Cochran's Q test and the I2 statistic. Subgroup analyses were planned by intervention category, surgical population, study design, comparator type, and primary outcome when at least two studies were available per subgroup. Sensitivity analyses were planned by excluding non-randomized studies, studies at high risk of bias, and active-comparator trials. Funnel plots and Egger's test were used only when at least 10 studies contributed to an outcome; otherwise, publication-bias testing was considered statistically unreliable. Mechanistic synthesis was conducted only for studies directly reporting inflammatory markers, microbial contamination, perfusion, exudate, collagen remodeling, oxidative stress, or other biological endpoints. Mechanistic explanations were not inferred from SSI reduction alone.